Discourse and Dissent
Like any area of scientific discovery, the field of neuromodulation depends heavily on timely and open dissemination of research findings and trial results. Traditionally, scientific journals have filled this function and the peer-review process that determines which papers get published provides the essential feedback that helps build consensus among the key stakeholders in the field. This feedbac…
BCI Competitors Race to Rack Up Human Participants
The market for brain computer interfaces continued to heat up in recent weeks as several vendors announced new milestones in human implantations. As we have noted in previous issues of this publication, the number of new firms entering the space and the amount of venture funding being distributed to startups surpasses any other product category we have seen in the 25 years we have been covering the neurotechnology industry.
Interferential Current Stim Offers New Strategies for VNS
The vagus nerve has proven to be a critical target for a number of potential new bioelectronic medicine therapies. But at the same time, this nerve has confounded research teams and startup firms pursuing indications such as heart failure and inflammatory disorders. A recent paper highlights some of the attributes of this complex nerve that make commercializing new therapies so difficult, including…
MedTech Innovator Accelerates Neurotech Commercialization
MedTech Innovator, based in Los Angeles, CA, is not venture capital firm in the strict sense. But the organization has played a significant role in helping launch a number of neurotech industry startup. MedTech Innovator bills itself as the world’s largest accelerator for medical device, digital health, and diagnostic companies. Its mission is to improve the lives of patients companies that are transforming the healthcare system.
Deciphering BCIs
The market for brain-computer interfaces continues to expand, with new players and new financing being announced almost weekly. As we report in our article on page 1 of this issue, some of the earliest competitors in this space are engaged in a race to accumulate new human participants in an effort to position themselves as a market leader, even though meaningful revenues are years away for most of these firms.
Neurotech Luminaries Look to the Future at SynBioBeta 2025
Neurotech Business Report Some of the nation’s leading neurotechnology researchers and entrepreneurs took to the stage at the recent SynBioBeta conference in San Jose, CA earlier this month to offer their views on the future of the field and its impact on society as a whole. A session called “The Neural Frontier: Pioneering Tomorrow’s Brain Technologies” was moderated , CEO of Forest Neurotech and…
Medtronic’s Diabetes Spinoff Offers Lessons for BioElectRx
Medtronic Inc., the Minneapolis, MN manufacturer of medical devices, has long been regarded as a powerhouse in neuromodulation and bioelectronic medicine. With sizable market share in product categories such as cardiac rhythm management, spinal cord stimulation, and bowel and bladder neuromodulation, the company has leveraged its engineering strength and market presence in multiple product categories.
Interferential Current Stim Offers New Strategies for VNS
The vagus nerve has proven to be a critical target for a number of potential new bioelectronic medicine therapies. But at the same time, this nerve has confounded research teams and startup firms pursuing indications such as heart failure and inflammatory disorders. A recent paper highlights some of the attributes of this complex nerve that make commercializing new therapies so difficult, including…
Draining the Brain
Many in the neurotechnology industry have come to lament some of the new policies that the incoming Trump administration has bestowed upon startups and researchers in the space. Much has made about the funding cuts, staff reductions, travel restrictions on government researchers and other clampdowns that threaten the U.S.’ preeminence in life science fields such as neurotechnology. But now a new th…
Panelists Discuss Policy Shifts at Bioelectronic Medicine Forum
Neurotech Business Report Neurotech Reports’ 2025 Bioelectronic Medicine Forum at the New York Academy of Medicine convened industry pioneers, investors, and innovators to explore the evolving landscape of bioelectronic medicine. The event illuminated both the challenges and transformative opportunities shaping this dynamic field, offering a blend of cautious optimism, regulatory insights, and groundbreaking technological advancements.